RELX
RELX Plc NYSE Listed Oct 6, 1994$31.18
-2.59%
vs $32.01
Mkt Cap $54.8B
52w Low $27.57
13.5% of range
52w High $54.37
50d MA $34.29
200d MA $38.47
P/E (TTM)
28.4x
EV/EBITDA
17.0x
P/B
24.0x
Debt/Equity
3.1x
ROE
—
P/FCF
20.6x
RSI (14)
43.20
ATR (14)
$0.80
Beta
0.23
50d MA
$34.29
200d MA
$38.47
Avg Volume
2.6M
RELX PLC provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals to progress in science and advance healthcare. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as increases the productivity. The Exhibitions segment is involved in the events business that combines face-to-face with data and digital tools to help customers learn about markets, source products, and complete transactions. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. The company was incorporated in 1903 and is headquartered in London, the United Kingdom.
1-3 Strand · London, X0 WC2N 5JR · GB
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | AMC | 0.85 | 0.79 | -6.7% | 28.81 | +6.4% | +7.8% | -2.0% | +0.3% | +1.4% | +1.5% | — |
| Jul 24, 2025 | AMC | 0.56 | 0.72 | +28.1% | 53.71 | -1.0% | -1.8% | -1.8% | +0.3% | -0.3% | +0.2% | — |
| Feb 14, 2025 | AMC | 0.80 | 0.64 | -19.1% | 51.07 | -0.0% | -0.4% | -0.7% | -0.2% | -2.2% | -0.2% | — |
| Oct 24, 2024 | AMC | 0.77 | 0.66 | -14.5% | 47.10 | +0.5% | +0.7% | +1.6% | -0.5% | -2.1% | -1.5% | — |
| Apr 25, 2024 | AMC | 0.73 | 0.60 | -16.7% | 41.12 | +0.6% | +1.2% | -0.1% | -0.9% | +0.1% | -0.0% | — |
| Jun 30, 2023 | AMC | 0.69 | 0.58 | -15.8% | 33.43 | -1.3% | -1.1% | -1.2% | -1.1% | -2.4% | +0.6% | — |
| Feb 16, 2023 | AMC | 0.67 | 0.56 | -16.3% | 29.84 | -0.6% | +0.7% | +0.1% | +1.8% | -0.1% | -1.1% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 3 | Goldman | Initiates | Buy | — | $33.38 | $33.55 | +0.5% | -1.4% | +4.7% | +2.0% | -1.8% | +1.2% |
| May 7 | Morgan Stanley | Downgrade | Overweight → Equal-Weight | — | $35.75 | $34.49 | -3.5% | -4.4% | -1.7% | -0.9% | -1.5% | -3.5% |
| Apr 8 | Citigroup | Upgrade | Neutral → Buy | — | $33.36 | $34.55 | +3.6% | +1.7% | -1.7% | -0.1% | +2.9% | +1.3% |
| Mar 14 | Barclays | Upgrade | Equal Weight → Overweight | — | $47.81 | $48.41 | +1.3% | +2.3% | +1.4% | -1.2% | +0.7% | +1.1% |
| Oct 4 | Goldman Sachs | Upgrade | Neutral → Buy | — | $33.31 | $34.27 | +2.9% | +3.2% | +1.4% | +0.9% | +0.1% | +1.1% |
| Mar 5 | UBS | Upgrade | Sell → Neutral | — | $25.11 | $24.43 | -2.7% | -2.4% | -1.2% | -7.6% | +1.5% | -4.4% |
| Mar 3 | BofA Securities | Maintains | Buy → Buy | — | $24.44 | $24.61 | +0.7% | +0.0% | +2.7% | -2.4% | -1.2% | -7.6% |
| Jan 21 | Citigroup | Upgrade | Neutral → Buy | — | $26.20 | $25.98 | -0.8% | -0.5% | +1.2% | +0.1% | +1.1% | -1.2% |
| Sep 24 | Barclays | Upgrade | Equal Weight → Overweight | — | $20.26 | $20.57 | +1.5% | +0.4% | +0.8% | +0.5% | +0.6% | +0.9% |
| Feb 12 | Barclays | Downgrade | Overweight → Equal Weight | — | $20.74 | $20.76 | +0.1% | +0.3% | -0.9% | +0.9% | +0.7% | +0.1% |
| Feb 9 | Deutsche Bank | Upgrade | Hold → Buy | — | $20.49 | $20.90 | +2.0% | +1.2% | +0.3% | -0.9% | +0.9% | +0.7% |
| Jan 10 | Goldman Sachs | Upgrade | Neutral → Buy | — | $23.43 | $23.23 | -0.9% | -1.2% | -1.0% | +1.3% | -0.1% | +0.1% |
| May 3 | Goldman Sachs | Downgrade | Buy → Hold | — | $18.16 | $17.94 | -1.2% | -1.5% | -0.4% | +0.0% | +0.8% | +0.7% |
| Nov 3 | Macquarie | Upgrade | Underperform → Neutral | — | $18.19 | $17.97 | -1.2% | -0.8% | -0.3% | -0.3% | -1.5% | +0.0% |
| Nov 2 | Macquarie | Upgrade | Underperform → Neutral | — | $18.02 | $18.08 | +0.3% | +0.9% | -0.8% | -0.3% | -0.3% | -1.5% |
No insider trades available.
No recent filings available.
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | 12,559,392 | $508M | Added | Dec 2025 |
| 2 | Arrowstreet Capital, Limited Partnership | 4,252,044 | $141M | Added | Mar 2026 |
| 3 | Bank Of America Corp /de/ | 4,180,034 | $139M | Reduced | Mar 2026 |
| 4 | Fmr Llc | 3,461,096 | $115M | Reduced | Mar 2026 |
| 5 | Northern Trust Corp | 3,028,448 | $100M | Added | Mar 2026 |
| 6 | Causeway Capital Management Llc | 2,306,409 | $76M | Added | Mar 2026 |
| 7 | Raymond James Financial Inc | 2,171,776 | $72M | Added | Mar 2026 |
| 8 | Aviso Financial Inc. | 1,797,213 | $60M | Added | Mar 2026 |
| 9 | Royal Bank Of Canada | 1,736,295 | $58M | Added | Mar 2026 |
| 10 | First Eagle Investment Management, Llc | 1,604,272 | $53M | New | Mar 2026 |
| 11 | Natixis Advisors, Llc | 1,405,920 | $47M | Added | Mar 2026 |
| 12 | Wells Fargo & Company/mn | 1,371,524 | $45M | New | Mar 2026 |
| 13 | Two Sigma Investments, Lp | 1,323,811 | $44M | Added | Mar 2026 |
| 14 | Millennium Management | 1,275,886 | $42M | Added | Mar 2026 |
| 15 | 1832 Asset Management L.p. | 1,254,106 | $42M | Added | Mar 2026 |
| 16 | Jpmorgan Chase & Co | 1,191,503 | $39M | Reduced | Mar 2026 |
| 17 | Renaissance Technologies Llc | 988,330 | $33M | Reduced | Mar 2026 |
| 18 | Invesco Ltd. | 867,410 | $29M | Added | Mar 2026 |
| 19 | Voya Investment Management Llc | 535,256 | $22M | New | Dec 2025 |
| 20 | Reynders Mcveigh Capital Management, Llc | 517,540 | $21M | Reduced | Dec 2025 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$54.85B
Enterprise Value
$63.04B
P/E (TTM)
28.35x
Forward P/E
22.00x
PEG Ratio
4.01x
P/B
23.97x
P/S
6.13x
P/FCF
20.58x
EV/EBITDA
16.96x
Shares Out
1.84B
Financials (TTM)
Revenue
$9.38B
Net Income
$2.02B
EBITDA
$3.72B
Free Cash Flow
$2.79B
Op Cash Flow
$2.81B
EPS Basic
$1.10
EPS Diluted
$1.10
EPS Forward
$1.42
Gross Margin
63.7%
Op Margin
31.1%
Net Margin
21.5%
Balance Sheet
Total Assets
$14.73B
Total Liab.
$12.35B
Total Equity
$2.39B
Cash
$130.8M
LT Debt
$5.69B
Book Value/Sh
$1.30
Debt/Equity
3.10x
Current Ratio
0.49
Quick Ratio
0.44
Returns & Growth
ROE
—
ROA
—
ROIC
21.4%
Rev Growth YoY
-0.6%
EPS Growth YoY
+6.8%
Price Returns
2W
+4.2%
1M
-10.4%
3M
-5.7%
6M
-18.5%
12M
-39.2%
Technicals
52W High
$54.37
52W Low
$27.57
50d MA
$34.29
200d MA
$38.47
RSI (14)
43.20
ATR (14)
$0.80
Beta
0.23
Avg Volume
2.6M
Dividends
Div Rate
$0.63
Div Yield
1.7%
Frequency
2
Ex-Div Date
May 8, 2026
Analyst Price Targets
Consensus
$26.00
High
$28.00
Low
$24.00
Median
$26.00
Data updated apr 26, 2026 10:26pm
· Source: financialmodelingprep.com